ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,562.43
1.04%
US Tech 100
19,316.80
1.62%
Dow Jones
40,383.72
0.24%
Brent Oil
81.635
-0.78%
Bitcoin
67,423.53
-1.07%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immunic Inc (IMUX)

  7. Immunic Inc (IMUX) News

IMUX

Immunic (IMUX)

Immunic Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMUX
DateTimeSourceHeadlineSymbolCompany
07/12/20248:31AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
07/12/20248:31AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
07/09/20246:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
07/09/20246:30AMPR Newswire (US)Immunic Appoints Jason Tardio as Chief Operating Officer and PresidentNASDAQ:IMUXImmunic Inc
06/12/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/12/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/10/20244:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMUXImmunic Inc
06/03/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMUXImmunic Inc
05/28/20246:30AMPR Newswire (US)Immunic to Participate in Industry and Scientific Conferences in JuneNASDAQ:IMUXImmunic Inc
05/24/20244:06PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:IMUXImmunic Inc
05/08/20247:20AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMUXImmunic Inc
05/08/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
05/08/20246:30AMPR Newswire (US)Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IMUXImmunic Inc
05/06/20246:30AMPR Newswire (US)Immunic to Participate in Investor and Scientific Conferences in MayNASDAQ:IMUXImmunic Inc
05/01/20246:30AMPR Newswire (US)Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate UpdateNASDAQ:IMUXImmunic Inc
04/30/20246:30AMPR Newswire (US)Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & NeuroinflammationNASDAQ:IMUXImmunic Inc
04/04/20246:30AMPR Newswire (US)Immunic to Host MS R&D Day and Participate in Investor Conferences in AprilNASDAQ:IMUXImmunic Inc
03/20/20246:30AMPR Newswire (US)Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United StatesNASDAQ:IMUXImmunic Inc
03/08/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
03/07/20246:30AMPR Newswire (US)Immunic to Participate in Investor and Scientific Conferences in MarchNASDAQ:IMUXImmunic Inc
03/06/20249:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
03/06/20249:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
03/06/20249:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
03/06/20249:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
03/06/20249:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
03/06/20249:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
02/29/20246:30AMPR Newswire (US)Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024NASDAQ:IMUXImmunic Inc
02/22/20246:38AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMUXImmunic Inc
02/22/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
 Showing the most relevant articles for your search:NASDAQ:IMUX

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
USOTC
MGON
Megola (PK)
NYSE
AMC
AMC Entertainment
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
GRLT
Grillit (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
CNNA
Cann American (CE)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
SHMP
NaturalShrimp (QB)
USOTC
SPZI
Spooz (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved